Content about Nephrology

September 4, 2012
Impax settles with Genzyme over kidney dialysis drugs

Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

July 31, 2012
MinuteClinic, American Heart Association collaborate for hypertension management

CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

July 2, 2012
The Little Clinic partners with University of Louisville Physicians

The Little Clinic has announced a collaborative affiliation with the University of Louisville Physicians’ Preventive Cardiology practice, which marks the third affiliation that The Little Clinic has formed with a medical group.

June 28, 2012
Botanical Labs launches gluten-free protein liquid supplement

Botanical Labs on Wednesday launched its certified gluten-free Protein Complete liquid dietary supplement that is fortified with 10 g of protein per 1-oz. serving.

June 19, 2012
Takeda: Edarbyclor demonstrates statistically superior blood-pressure reductions

A Takeda drug designed to treat hypertension was statistically superior to a competing drug in reducing systolic blood pressure among patients in a late-stage clinical trial.

June 7, 2012
Perrigo wins approval for renal failure drug

The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

April 27, 2012
FDA approves Novartis drug for tumors in patients with rare genetic disease

A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

April 10, 2012
Amgen to acquire Kai for $315 million

Biotech manufacturer Amgen will acquire the private South San Francisco, Calif.-based drug developer Kai Pharmaceuticals for $315 million, the companies said Tuesday.

March 28, 2012
FDA approves Omontys for kidney disease-related anemia

The Food and Drug Administration has approved a new treatment for anemia in patients with chronic kidney disease.

January 12, 2012
Active Health Foods rolls out Active X bar for dialysis patients

Active Health Foods has introduced an energy bar designed for dialysis patients.

December 21, 2011
FDA approves Takeda's Edarbyclor

The Food and Drug Administration has approved a new drug for high blood pressure made by Takeda, the drug maker said.

December 20, 2011
Study: High blood pressure in middle age fair predictor of heart attack, stroke

A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday.

September 23, 2011
FDA approves first-ever drug for rare blood disorder

The Food and Drug Administration has approved a treatment made by Alexion Pharmaceuticals for a rare blood disorder that affects children.

August 23, 2011
Publix offers free lisinopril to pharmacy patients

Publix announced that it now offers free 30-day supplies (up to 30 tablets) of lisinopril to customers with a prescription for the medication.

April 22, 2011
Study: Pirfenidone could improve kidney function among diabetic nephropathy patients

An investigational antifibrotic and anti-inflammatory drug could help treat a common complication of diabetes.

April 7, 2011
NAD to DSE Healthcare Solutions: Modify ads for Cystex products

The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that DSE Healthcare Solutions, which markets both Cystex urinary pain relief tablets and Cystex liquid cranberry complex with Proantinox, modify its advertising to better distinguish the two products.

March 7, 2011
Keryx to present phase-3 clinical data for Zerenex at conference

Late-stage clinical trial data for a Keryx Biopharmaceuticals drug to treat kidney disease will be presented at a medical conference in Las Vegas.

February 28, 2011
Takeda's Edarbi approved as hypertension treatment

The Food and Drug Administration has approved a new treatment for hypertension, also known as high blood pressure, the agency said Friday.

February 25, 2011
Type 1 diabetics continue to be at risk for kidney disease

Advances in kidney care have not led to successful efforts to improve therapy for patients with Type 1 diabetes, according to a study published in the Journal of the American Society of Nephrology.

February 24, 2011
Takeda seeks FDA approval for hypertension treatment

Drug maker Takeda has filed for regulatory approval of a drug to treat hypertension, the company said Wednesday.

February 8, 2011
Vascugel granted fast-track designation by FDA

The Food and Drug Administration has given expedited review to a drug for preventing hemodialysis failure in patients with end-stage kidney disease.

February 1, 2011
CVS study: Adherence shrinks health costs

Pharmacy and health policy advocates endlessly tout the cost-saving 
benefits of improved medication adherence. In January, CVS Caremark put more teeth into that argument with some dramatic new findings that should get the attention of every health plan payer.


December 23, 2010
FDA approves Novartis drug for high blood pressure treatment

The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company.

December 1, 2010
Keryx: Zerenex reduces phosphate levels in patients on kidney dialysis

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

November 21, 2010
Vytorin helps reduce cardiac events in chronic kidney disease patients

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

© 2013 Drug Store News. All Rights Reserved.